Pat Cotroneo
2020
Compensation breakdown
| Non-Equity Incentive Plan | $230,937 |
|---|---|
| Option Awards | $1,061,723 |
| Salary | $508,000 |
| Stock Awards | $1,056,400 |
| Other | $58,959 |
| Total | $2,916,018 |
Cotroneo received $1.1M in option awards, accounting for 36% of the total pay in 2020.
Cotroneo also received $230.9K in non-equity incentive plan, $508K in salary, $1.1M in stock awards and $59K in other compensation.
Rankings
In 2020, Pat Cotroneo's compensation ranked 3,970th out of 13,090 executives tracked by ExecPay. In other words, Cotroneo earned more than 69.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,970 out of 13,090 | 70th |
Division Manufacturing | 1,591 out of 5,621 | 72nd |
Major group Chemicals And Allied Products | 602 out of 2,254 | 73rd |
Industry group Drugs | 520 out of 1,954 | 73rd |
Industry Pharmaceutical Preparations | 394 out of 1,459 | 73rd |
Pay ratio
| Pat Cotroneo's Pay | $2,916,018 |
|---|---|
| Median Employee's Pay | $177,952 |
| Pay Ratio | 16to 1 |
In 2020, the annual total compensation of Pat Cotroneo was $2,916,018.
The annual total compensation of the median employee at FibroGen was $177,952.
The ratio of Pat Cotroneo's pay to the pay of median employee was therefore 16 to one.
Cotroneo's colleagues
We found seven more compensation records of executives who worked with Pat Cotroneo at FibroGen in 2020.
2020
Enrique Conterno
FibroGen
Chief Executive Officer
2020
Thane Wettig
FibroGen
Chief Commercial Officer
2020
Mark Eisner
FibroGen
Chief Medical Officer
2020
K Yu
FibroGen
Chief Medical Officer
2020
Elias Kouchakji
FibroGen
Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance
2020
Christine Chung
FibroGen
Senior Vice President, China Operations
2020
James Schoeneck
FibroGen